Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Clinical trial NCT06043674 · RECRUITING
Trial details
- NCT number
- NCT06043674
- Sponsor
- Christine Ryan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2028-01-15
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.